Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial
収録刊行物
-
- The Lancet
-
The Lancet 387 (10014), 136-145, 2016-01
Elsevier BV